Drug Trial Radar · NCT03586427
Zelquistinel in the Treatment of Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
251
Actual
Start
Jun 13, 2018
Primary completion
Jul 22, 2019
Study completion Aug 21, 2019
Sponsor
- Lead sponsor
- Syndeio Biosciences, IncIndustry
- Sponsor type
- Industry
- First posted
- Jul 13, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy at 1 day post initial oral dose of zelquistinel (AGN-241751) compared with placebo in participants with Major Depressive Disorder (MDD).
Conditions
- Depressive Disorder, Major
Interventions
AGN-241751Drug
AGN-241751 administered orally as a single tablet
PlaceboDrug
Placebo administered orally as a single tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total ScoreTime frame: Baseline to Day 1
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Health Initiatives Research PLLC
Fayetteville, Arkansas
Synexus US - Cerritos
Cerritos, California
Wake Research - Pharmacology Research Institute
Encino, California
Wake Research - Pharmacology Research Institute
Newport Beach, California
Pacific Research Partners, LLC
Oakland, California
North County Clinical Research, Inc.
Oceanside, California
Collaborative Neuroscience Network
Torrance, California
Elite Clinical Trials, Inc.
Wildomar, California
Synexus US - Atlanta
Atlanta, Georgia
Atlanta Center for Medical Research
Atlanta, Georgia
Pillar Clinical Research
Lincolnwood, Illinois
Boston Clinical Trials
Boston, Massachusetts
Hassman Research Institute
Berlin, New Jersey
Center for Emotional Fitness
Cherry Hill, New Jersey
Neurobehavioral Research, Inc
Cedarhurst, New York
Synexus US - Queens
Jamaica, New York
Eastside Comprehensive Medical Center
New York, New York
Finger Lakes Clinical Research
Rochester, New York
Neuro-Behavioral Clinical Research, Inc
North Canton, Ohio
IPS Research
Oklahoma City, Oklahoma
Clinical Neuroscience Solutions, Inc - Memphis, TN
Memphis, Tennessee
Research Strategies of Memphis, LLC
Memphis, Tennessee
Donald J. Garcia, Jr., MD, PA
Austin, Texas
FutureSearch Trials of Dallas, LP
Dallas, Texas
Northwest Clinical Research Center
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.